Abstract
Autism is a neurodevelopmental disorder characterized by presence of social deficits, language abnormalities, stereotypies, and repetitive behavior. Brain pathology is extensive, suggesting widespread dysfunction of neurotransmitter systems. Genetic, biochemical, and gene association studies have shown that a number of neurotransmitters including serotonin, dopamine, oxytocin, GABA and glutamate, and acetylcholine contribute to the pathology of autism. Pharmacological treatment of autism has focused on reduction of symptoms and atypical antipsychotics, antidepressants, mood stabilizers, and anticonvulsants have been shown to successfully reduce many symptoms of autism. In this review we discuss the contributions of neurotransmitter systems to the pathology of autism and pharmacological treatment of autistic symptoms associated with neurochemical dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acosta MT, Pearl PL (2003) The neurobiology of autism: new pieces of the puzzle. Curr Neurol Neurosci Rep 3:149–156
Amara SG, Pacholczyk T (1991) Sodium-dependent neurotransmitter reuptake systems. Curr Opin Neurobiol 1:84–90
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA Press, Washington, DC
Anderson GM (2005) Serotonin in autism. In: Bauman ML, Kemper TL (eds) The Neurobiology of Autism. Johns Hopkins University Press, Baltimore, MD, pp 303–318
Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, Minderaa RB, Hansen CR, Young JG (1987) Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 28:885–900
Bailey A, Phillips W, Rutter M (1996) Autism: towards an integration of clinical, genetic, neuropsychological and neurobiological perspectives. J Child Psychol Psychiatry 37:89–126
Bauman ML, Kemper TL (1994) Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL (eds) The neurobiology of autism. Johns Hopkins University Press, Baltimore, MD, pp 19–145
Bauman ML, Kemper TL (2005) Structural brain anatomy in autism: what is the evidence? In: Bauman ML, Kemper TL (eds) The neurobiology of autism. Johns Hopkins University Press, Baltimore, MD, pp 121–135
Beninger RJ, Banasikowski TJ (2008) Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor. Neurotox Res 14:57–70
Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355–366
Binnie CD (1993) Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children. Brain Dev 15:23–30
Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 31:537–544
Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, Paolucci M, Abbott A, Ragoussis I, Poustka A, Bailey AJ, Monaco AP (2003) International Molecular Genetic Study of Autism (IMGSAC). Analysis of reelin as a candidate gene for autism. Mol Psychiatry 10:885–892
Boulougouris V, Tsaltas. E (2008) Serotonergic and dopaminergic modulation of attentional processes. Prog Brain Res 172:517–542
Bowery NG (2000) GABAB receptors structure and function. In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott Williams and Wilkins, Philadelphia, PA, pp 233–244
Brandon NJ, Smart TG, Moss SJ (2000) Regulation of GABAA Receptors by protein phosphorylation. In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott Williams and Wilkins, Philadelphia, PA, pp 191–206
Butkevich IP, Khozhai LI, Mikhailenko VA, Otellin VA (2003) Decreased serotonin level during pregnancy alters morphological and functional characteristics of tonic nociceptive system in juvenile offspring of the rat. Reprod Biol Endocrinol 1:96
Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE (1997) Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 36:835–843
Canitano R, Scandurra V (2008) Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 4:723–730
Carlson NR (2001) Physiology of behavior. Allyn and Bacon, Boston, MA
Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ (2004) Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 19:165–169
Choleris E, Gustafsson JA, Korach KS, Muglia LJ, Pfaff DW, Ogawa S (2003) An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice. Proc Natl Acad Sci U S A 100:6192–6197
Cohen DJ, Caprulo BK, Shaywitz BA, Bowers MB Jr (1977) Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 34:545–550
Cohen DJ, Shaywitz BA, Johnson WT, Bowers MB Jr (1974) Biogenic amines in autistic and atypical children: cerebrospinal fluid measures of homovillic acid and 5-hydroxyindoleacetic acid. Arch Gen Psychiatry 31:845–853
Comings DE, Gade R, Muhleman D, Sverd J (1995) No association of a tyrosine hydroxylase gene tetranucleotide repeat polymorphism in autism, Tourette syndrome, or ADHD. Biol Psychiatry 37:484–486
Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8:348–354
Cools R (2008) Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist 14:381–395
Cooper J, Howell BW (1999) Lipoprotein receptors: signaling function in the brain? Cell 97:671–674
Couturier JL, Nicolson R (2002) A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol 12:243–248
Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL, Cook EH Jr, Veenstra-Vanderweele J (2008) Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 33:353–360
D’Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24:471–479
Davis E, Fennoy I, Laraque D, Kanem N, Brown G, Mitchell J (1992) Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 84:315–319
DeBergeyck V, Naerhuyzen B, Goffinet AM, deRouvroit C (1998) A panel of monoclonal antibodies against Reelin, the extracellular matrix protein defective in reeler mutant mice. J Neurosci Methods 82:17–24
de Krom M, Staal WG, Ophoff RA, Hendriks J, Buitelaar J, Franke B, de Jonge MV, Bolton P, Collier D, Curran S, van Engeland H, van Ree JM (2008) A common variant in DRD3 receptor is associated with Autism spectrum disorder. Biol Psychiatry 65(7):625–630
DeLong GR, Teague LA, McSwain Kamran M (1998) Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol 40:551–562
Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W, Minshew N, Pauls D, Smith M, Spence MA, Rodier PM, Stodgell C, Schellenberg GD; CPEA Genetics Network (2004) Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. Am J Med Genet 126B:46–50
Dhossche D, Applegate H, Abraham A, Maertens P, Bland L, Bencsath A, Martinez J (2002) Elevated plasma gama-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for GABA hypothesis of autism. Med Sci Mon 8:PR1–PR6
Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, Kreidberg JA, Anton ES (2000) Reelin binds alpha 3 beta 1 integrin and inhibits neuronal migration. Neuron 27:33–44
Engelmann M, Ebner K, Wotjak CT, Landgraf R (1998) Endogenous oxytocin is involved in short-term olfactory memory in female rats. Behav Brain Res 90:89–94
Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin A (1991) Two genes encode distinct glutamate deoxycarbolases. Neuron 7:97–100
Fatemi SH (2008) The hyperglutamatergic hypothesis of autism. Prog Neuropsychopharmacol Biol Psychiatry 32:911
Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD (2009a) Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 8(1):64–69
Fatemi SH, Halt A, Stary J, Kanodia R, Schulz SC, Realmuto G (2002a) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in parietal and cerebellar cortices of autistic subjects. Biol Psychiatry 52:805–810
Fatemi SH, Realmuto GM, Khan L, Thuras P (1998) Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial. J Autism Dev Disord 28:303–307
Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G (2008) Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 99:56–70
Fatemi SH, Reutiman TJ, Folsom TD, Rooney RJ, Patel DH, Thuras P (2010) mRNA and protein levels for GabaAalpha4, alpha5, beta1, and GABABR1 receptors are altered in brains from subjects with autism. J Autism Dev Disord 40:743–750
Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009b) GABA(A) Receptor Downregulation in Brains of Subjects with Autism. J Autism Dev Disord 39:223–230
Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Brooks AI, Pearce DA, Reutiman TJ, Lee S (2005) Reelin signaling is impaired in autism. Biol Psychiatry 57:777–787
Fatemi SH, Stary JM, Egan EA (2002b) Defective Reelin production as a vulnerability factor in genesis of autism. Cell Mol Neurobiol 22:139–152
Fatemi SH, Stary JM, Halt AR, Realmuto GR (2001) Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 6:529–535
Ferguson JN, Aldag JM, Insel TR, Young LJ (2001) Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 21:8278–8285
Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT (2000) Social amnesia in mice lacking the oxytocin gene. Nat Genet 25:284–288
Forster E, Tielsch A, Saum B, Weiss KH, Johanssen C, Graus-Porta D, Muller U, Frotscher M (2002) Reelin, disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus. Proc Natl Acad Sci U S A 99:13178–13183
Fox SH, Chuang R, Brotchie JM (2008) Parkinson’s disease–opportunities for novel therapeutics to reduce the problems of levadopa therapy. Prog Brain Res 172:479–494
Gillberg C, Svennerholm L (1987) CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 151:89–94
Gillberg C, Svennerholm L, Hamilton-Hellberg C (1983) Childhood psychosis and monoamine metabolites in spinal fluid. J Autism Dev Disord 13:383–396
Green L, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50:609–613
Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E (2005) GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) 180:191–205
Han Y, Qin J, Bu DF, Chang XZ, Yang ZX (2006) Successive alterations of hippocampal gamma-aminobutyric acid B receptor subunits in a rat model of febrile seizure. Life Sci 8:2944–2952
Hardan AY, Handen BL (2002) A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 12:237–241
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624
Hertzman M (2003) Galantamine in the treatment of adult autism: a report of three clinical cases. Int J Psychiatry Med 33:395–398
Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J (1999) Direct biding of Reelin to VLDL receptor and ApoE receptor 2 induces tyroene phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24:481–489
Hohnadel E, Bouchard K, Terry AV Jr (2007) Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats. Neuropharmacology 52:542–551
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S (2007) Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61:498–503
Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S (2003) Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology 28:193–198
Hranilović D, Bujas-Petković Z, Tomicić M, Bordukalo-Niksić T, Blazević S, Cicin-Sain L (2009) Hyperserotonemia in autism: activity of 5-HT-associated platelet proteins. J Neural Transm 116:493–501
Hranilović D, Novak R, Babić M, Novokmet M, Bujas-Petković Z, Jernej B (2008) Hyperserotonemia in autism: the potential role of 5HT-related gene variants. Coll Antropol 32:75–80
Huang CH, Santangelo SL (2008) Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B:903–913
Insel TR, O’Brien DJ, Leckman JF (1999) Oxytocin, vasopressin, and autism: is there a connection? Biol. Psychiatry 45:145–157
Insel TR, Young LJ (2000) Neuropeptides and the evolution of social behavior. Curr Opin Neurobiol 10:784–789
Jacob S, Brune CW, Carter CS, Leventhal BL, Lord C, Cook EH Jr (2007) Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett 417:6–9
Johnsoton GA, Chebib M, Hanrahan JR, Mewett KN (2003) GABA(C) receptors as drug targets. Curr Drug Targets CNS Neurol Disord 2:260–268
Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M et al (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674–679
Kandel, ER, Schwartz, JH, Jessell, TH (eds) (1995) Essentials of neuroscience and behavior. Appleton and Lange, Norwalk, CT
Kramer K, Azmitia EC, Whitaker-Azmitia PM (1994) In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Brain Res Dev Brain Res 78:142–146
Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M (2002) Paris Autism Research International Sibpair (PARIS) study. Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol Psychiatry 7:801–804
Kuriyama K, Hirouchi M, Kimura H (2000) Neurochemical and molecular pharmacological aspects of the GABA(B) receptor. Neurochem Res 25:1233–1239
Lam KS, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27:254–289
Laprade N, Soghomonian JJ (1999) Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differently altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33:36–48
Lauritsen MB, Børglum AD, Betancur C, Philippe A, Kruse TA, Leboyer M, Ewald H (2002) Investigation of two variants in the DOPA decarboxylase gene in patients with autism. Am J Med Genet 114:466–470
Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E (2002) Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125:1483–1495
Lerer E, Levi S, Salomon S, Darvasi A, Yirmiya N, Ebstein RP (2008) Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland adaptive behavior scales and cognition. Mol Psychiatry 13:980–988
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531
Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N, Myers RM (2004) Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet 126B:51–57
Light KJ, Joyce PR, Luty SE, Mulder RT, Frampton CM, Joyce LR, Miller AL, Kennedy MA (2006) Preliminary evidence for an association between a dopamine D3 receptor gene variant and obsessive-compulsive personality disorder in patients with major depression. Am J Med Genet B Neuropsychiatr Genet 141:409–413
Lugli G, Krueger JM, Davis JM, Persico AM, Keller F, Smalheiser NR (2003) Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem 4:9
Luque JM, Morante-Oria J, Fairen A (2003) Localization of ApoER2, VLDLR and Dab-1 in radial glia: groundwork for a new model of Reelin action during cortical development. Dev Brain Res 140:195–203
Ma DQ, Whitehead PL, Menold MM, Martin ER, Ashley-Koch AE, Mei H, Ritchie MD, Delong GR, Abramson RK, Wright HH, Cuccaro ML, Hussman JP, Gilbert JR, Pericak-Vance MA (2005) Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 77:377–388
Martin A, Koenig K, Anderson GM, Scahill L (2003) Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Autism Dev Disord 33:77–85
Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK (2004) Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 123:81–90
Martineau J, Hérault J, Petit E, Guérin P, Hameury L, Perrot A, Mallet J, Sauvage D, Lelord G, Müh JP (1994) Catecholaminergic metabolism and autism. Dev Med Child Neurol 36:688–697
McBride PA, Anderson GM, Hertzig ME, Snow ME, Thompson SM, Khait VD, Shapiro T, Cohen DJ (1998) Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry 37:767–776
McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH (1996a) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:993–1000
McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH (1996b) A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53:1001–1008
McDougle CJ, Stigler KA, Erickson CA, Posey DJ (2008) Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry 69:15–20
Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1989) Neurochemical study of dopamine functioning in autistic and normal subjects. J Am Acad Child Adolesc Psychiatry 28:190–194
Modahl C, Green L, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H (1998) Plasma oxytocin levels in autistic children. Biol Psychiatry 43:270–277
Moore ML, Eichner SF, Jones JR (2004) Treating functional impairment of autism with selective serotonin-reuptake inhibitors. Ann Pharmacother 38:1515–1519
Moreno H, Borjas L, Arrieta A, Salz L, Prassad A, Estevez J, Bonilla E (1992) Clinical heterogeneity of the autistic syndrome: a study of 60 families. Invest Clin 33:13–31
Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L (1996) Plasma excitatory amino acids in autism. Invest Clin 37:113–128
Narayan M, Srinath S, Anderson GM, Meundi DB (1993) Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 33:630–635
Nicholson R, Craven-Thuss B, Smith J (2006) A prospective, open-label trial of galantamine in autistic disorder. J Child Adolesc Psychopharmacol 16:621–629
Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL (2003) Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8(895):933–936
Palmen SJ, van Engeland H, Hof PR, Schmitz C (2004) Neuropathological findings in autism. Brain 127:2572–2583
Pan JW, Lane JB, Hetherington H, Percy AK (1999) Rett Syndrome: H-1 spectroscopic imaging at + 1 Tesla. J Child Neurol 14:524–528
Peral M, Alcami M, Gilaberte I (1999) Fluoxetine in children with autism. J Am Acad Child Adolesc Psychiatry 38:1472–1473
Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 158:1058–1066
Persico AM, D’Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink TH, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Conciatori M, Marino R, Quattrocchi CC, Baldi A, Zelante L, Gasparini P, Keller F; Collaborative Linkage Study of Autism (2001) Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 6:150–159
Philippe A, Guilloud-Bataille M, Martinez M, Gillberg C, Råstam M, Sponheim E, Coleman M, Zappella M, Aschauer H, Penet C, Feingold J, Brice A, Leboyer M; Paris Autism Research International Sibpair Study (2002) Analysis of ten candidate genes in autism by association and linkage. Am J Med Genet 114:125–128
Popik P, Vetulani J, van Ree JM (1992) Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology (Berl) 106:71–74
Posey DJ, Erickson CA, McDougle CJ (2008) Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am 17:787–801
Princivalle AP, Duncan JS, Thom M, Bowery NG (2003b) GABA(B1a), GABA(B1b) and GABA(B2) mRNA variants expression in hippocampus resected from patients with temporal lobe epilepsy. Neuroscience 122:975–984
Princivalle AP, Richards DA, Duncan JS, Spreafico R, Bowery NG (2003a) Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res 55:39–51
Qian H, Ripps H (2008) Focus on molecules: the GABA(C) receptor. Exp Eye Res 88(6):1002–1003
Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P (1991) GABA and pancreatic beta cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10:1275–1284
Ross DL, Klykylo WM, Anderson GM (1985) Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Ann Neurol 18:394
Shemer A, Whitaker-Azmitia PM, Azmitia EC (1988) Effects of prenatal 5-methoxytryptamine and parachlorophenylalanine on serotonergic uptake and behavior in the neonatal rat. Pharmacol Biochem Behav 30:847–851
Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23:297–302
Soghomonian JJ, Martin DL (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19:500–505
Steingard RJ, Zimnitzky B, DeMaso DR, Bauman ML, Bucci JP (1997) Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J Child Adolesc Psychopharmacol 7:9–15
Straessle A, Loup F, Arabadzisz D, Ohning GV, Fritschy JM (2003) Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy. Eur J Neurosci 18:2213–2226
Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, Hiesberger T, Herz J, Weeber EJ, Sweatt JD, Pramatarova A, Howell B, Schneider WJ, Nimpf J (2004) Receptor clustering is involved in reelin signaling. Mol Cell Biol 24:1378–1386
Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K (2005) Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci U S A 102:16096–16101
Tuchman R, Rapin I (2002) Epilepsy in autism. Lancet Neurol 1:352–358
Waterhouse L, Fein D, Modahl C (1996) Neurofunctional mechanisms in autism. Psychol Rev 103:457–489
Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944–39952
Whitaker-Azmitia PM (2001) Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479–485
Whitaker-Azmitia PM (2005) Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci 23:75–83
Whitaker-Azmitia PM, Lauder JM, Shemmer A, Azmitia EC (1987) Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin receptors. Brain Res 430:285–289
Winsberg BG, Sverd J, Castells S, Hurwic M, Perel JM (1980) Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children. Neuropediatrics 11:250–255
Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G, Fatemi SH (2008) Dopamine and serotonin levels following prenatal viral infection in mouse–implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18:712–716
Wu S, Jia M, Ruan Y, Liu J, Guo Y, Shuang M, Gong X, Zhang Y, Yang X, Zhang D (2005) Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 58:74–77
Yip J, Soghomonian JJ, Blatt GJ (2007) Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol 113:559–568
Ylisaukko-oja T, Alarcón M, Cantor RM, Auranen M, Vanhala R, Kempas E, von Wendt L, Järvelä I, Geschwind DH, Peltonen L (2006) Search for autism loci by combined analysis of autism genetic resource exchange and finnish families. Ann Neurol 59:145–155
Yrigollen CM, Han SS, Kochetkova A, Babitz T, Chang JT, Volkmar FR, Leckman JF, Grigorenko EL (2008) Genes controlling affiliative behavior as candidate genes for autism. Biol Psychiatry 63:911–916
Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR, Guidotti AR, Holden JJ (2002) Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 7:1012–1017
Acknowledgments
Grant support by National Institute of Child Health and Human Development (#5R01HD052074-01A2 and #3R01KD052074-03S1) to SHF is gratefully acknowledged
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Folsom, T.D., Fatemi, S.H. (2011). Neurochemistry of Autism. In: Blass, J. (eds) Neurochemical Mechanisms in Disease. Advances in Neurobiology, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7104-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7104-3_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7103-6
Online ISBN: 978-1-4419-7104-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)